R. Rodby

E. Lewis, R. Atkins, R. Rodby, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease

D. Fine, R. Rodby, J. Weinreb, 2020, Kidney medicine.

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

D. Fine, R. Rodby, J. Weinreb, 2020, Radiology.

Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics. The Collaborative Study Group for The study of Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy.

E. Lewis, R. Rodby, R. Rohde, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An Evidence-Based Approach: The Emerging Role of Renal Protection in Hypertension; A Focus on Clinical and Economic Factors That Impact Formulary Decision Making

S. J. Lewis, R. Rodby, L. Hunsicker, 2004, Journal of Managed Care Pharmacy : JMCP.

A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.

J. Lewis, R. Rodby, Y. Shyr, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension

P. Lapuerta, H. Parving, R. Rodby, 2006, Current medical research and opinion.

Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.

P. Lapuerta, H. Parving, R. Rodby, 2005, Kidney international. Supplement.

Economic evaluation of the use of irbesartan and amlodipine in the treatment of diabetic nephropathy in patients with hypertension in Canada.

D. Coyle, R. Rodby, 2004, The Canadian journal of cardiology.

[Cost-efectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective].

R. Rodby, A. Palmer, L. Annemans, 2004, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings.

R. Rodby, A. Palmer, L. Annemans, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Cost-Effectiveness of lrbesartan in the Treatment of Hypertensive Patients with Type 2 Diabetic Nephropathy

E. Lewis, R. Rodby, N. Sengupta, 2003 .

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

E. Lewis, R. Rodby, R. Gilbert, 2005, Journal of the American Society of Nephrology : JASN.

Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease

B. Rovin, D. Fine, M. Bissell, 2013, Annals of the rheumatic diseases.

Reproducibility of studies of peritoneal dialysis adequacy.

R. Rodby, S. Korbet, C. Firanek, 1996, Kidney international.

A Controlled Clinical Trial of Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy: Study Design and Patient Characteristics

Mark E. Williams, J. Breyer, R. Bain, 1992 .

Elevated serum creatinine in a patient with normal renal function: The value of Cystatin C

R. Rodby, S. Korbet, S. Sahota, 2015, Nephrology.

Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

D. Fine, R. Rodby, J. Weinreb, 2020, Kidney medicine.

Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.

R. Rodby, M. Perazella, 2007, The American journal of medicine.

Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern

R. Rodby, M. Perazella, 2007, Seminars in dialysis.

Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO.

R. Rodby, 2020, Kidney360.

Can gadolinium be given safely to a patient on dialysis?

R. Rodby, 2011, Seminars in dialysis.

Agrobacterium radiobacter peritonitis in two patients maintained on chronic peritoneal dialysis.

R. Rodby, E. Glick, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hemoglobin-AGE: a circulating marker of advanced glycosylation.

E. Friedman, R. Rodby, R. Bucala, 1992, Science.

Antihypertensive treatment in nephropathy of type II diabetes: role of the pharmacological blockade of the renin-angiotensin system.

R. Rodby, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Peritoneal Membrane Failure: Differential Diagnosis, Evaluation, and Treatment

R. Rodby, S. Korbet, 1994 .

Type II diabetic nephropathy: its clinical course and therapeutic implications.

R. Rodby, 1997, Seminars in nephrology.

Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data

R. Rodby, J. Dwyer, Marvin V Sinsakul, 2014, Expert review of clinical pharmacology.

Management of the Systemic Lupus Erythematosus Patient with End‐Stage Renal Disease

R. Rodby, 1989 .

PDG17: AN ECONOMIC ANALYSIS OF IRBESARTAN IN TYPE II DIABETIC NEPHROPATHY

G. L’italien, E. Lewis, R. Rodby, 2001 .

Proteinuria, hematuria, hypertension, and decreased renal function in a patient with diabetes for 9 years.

R. Rodby, M. Schwartz, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome.

R. Rodby, P. Subbaiah, 1994, Metabolism: clinical and experimental.

New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.

N. Powe, V. Gudnason, A. Rule, 2021, The New England journal of medicine.

Amputations associated with arteriovenous access.

R. Rodby, S. Jensik, J. Nicholas, 2000, American journal of physical medicine & rehabilitation.

[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy].

R. Rodby, H. Lehnert, E. Ritz, 2006, Deutsche medizinische Wochenschrift.

An Elevated Hemidiaphragm 3 Months After Internal Jugular Vein Hemodialysis Catheter Placement

R. Rodby, E. Serdaroğlu, S. Mir, 2003, Seminars in dialysis.

Changing Trends in the Performance of Percutaneous Renal Biopsy from Nephrologist to Interventional Radiologist: A Single-Center Experience

R. Rodby, W. Whittier, S. Korbet, 2018, American Journal of Nephrology.

Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation.

R. Rodby, J. Williams, T. S. Tyszka, 1991, The American journal of medicine.

Special articleReversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation

R. Rodby, James W. Williams, T. S. Tyszka, 1991 .

Vaccination of the Dialysis Patient

R. Rodby, G. Trenholme, 1991 .

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

D. Fine, R. Rodby, J. Weinreb, 2020, Radiology.

When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.

P. Venugopal, P. Hari, R. Rodby, 2019, Clinical lymphoma, myeloma & leukemia.

Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.

R. Rodby, A. Justice, D. Hricik, 1998, Kidney international.

NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Dialytic Therapies to Prevent NSF Following Gadolinium Exposure in High‐Risk Patients

R. Rodby, 2008, Seminars in dialysis.

Successful treatment of refractory hypertension with bilateral nephrectomy in a patient with chronic kidney disease stage 3

G. Bakris, R. Rodby, M. Hertl, 2021, Clinical kidney journal.

Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs

J. Lewis, R. Rodby, J. Dwyer, 2015, Expert review of pharmacoeconomics & outcomes research.

Renal transplant arterial thrombosis: association with cyclosporine.

R. Rodby, S. Jensik, S. Korbet, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An 18-year-old man with Goodpasture's syndrome and ANCA-negative central nervous system vasculitis.

R. Rodby, J. Rydel, James J. Rydel, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Timed Urine Collections for Albumin and Protein: "The King Is Dead, Long Live the King!"

R. Rodby, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Accelerated venovenous hemofiltration: early technical and clinical experience.

R. Rodby, S. Salcedo, Casey N Gashti, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hemofiltration for SIRS: bloodletting, twentieth century style?

R. Rodby, 1998, Critical care medicine.

Unexpectedly Severe Metabolic Acidosis Associated with Sodium Thiosulfate Therapy in a Patient with Calcific Uremic Arteriolopathy

R. Rodby, Natalie Selk, 2011, Seminars in dialysis.

Aliquot versus Batch Sampling Methods for Measurements of Peritoneal Dialysis Adequacy in Patients Receiving CAPD

R. Rodby, C. Firanek, 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Rapid Reversal of Bone Scan Abnormalities in a Patient With Type 1 Primary Hyperoxaluria and Oxalosis

R. Rodby, Amjad Ali, A. Ali, 1994, Clinical nuclear medicine.

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group.

R. Bain, E. Lewis, R. Rodby, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Shortness of Breath and Abdominal Pain Within Minutes of Starting Hemodialysis

R. Rodby, A. Bellucci, 2004, Seminars in dialysis.

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

R. Rodby, A. Palmer, W. Valentine, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Accuracy of a GFR estimating equation over time in people with a wide range of kidney function.

G. Beck, C. Schmid, H. Tighiouart, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

G. Beck, L. Stevens, A. Levey, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Nonuremic Uses for Dialysis

R. Rodby, 1995 .

Percutaneous Renal Biopsy Using an 18-Gauge Automated Needle Is Not Optimal

R. Rodby, S. Korbet, V. Peev, 2021, American Journal of Nephrology.

Clinical and pathologic features of familial focal segmental glomerulosclerosis.

R. Rodby, J. Gunnells, D. Howell, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data

J. Lewis, R. Rodby, J. Dwyer, 2015, Drugs in R&D.